Medifast's Q4 Guidance Remains Weak: When Does Growth Return?

Key Takeaways MED guided Q4 revenue in the range of $65M-$ 80M with a loss per share of 70 cents - $1.25.MED Q3 revenue fell 36.2% as active earning coaches dropped 35% year over year.MED expects stabilization as coach productivity improves and metabolic health initiatives roll out.Medifast, Inc.’s (MED) guidance for the fourth quarter of 2025 remains weak, with revenue projected to be between$ 65 million and $80 million and a loss per share ranging from 70 cents to$ 1.25. This reflects quite a deterioration ...